Investigator
Daniel H Kaplan
UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NIAMS
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $1.1M
- First award
- Mar 1, 2017
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jul 20, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Mezzion Pharma Co. Ltd53momentum
OncologyPhase II
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Intrinsic and Extrinsic factors regulating competition for active TGFb promote skin memory CD8 T cell fitness
$581kJul 20, 2024NIAMSUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11140479 (opens the source filing in a new tab)
- R01
Immune Functions of Cutaneous Nociceptors
$491kMar 1, 2017NIAMSUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11095711 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources